Gel Documentation Systems companies

  • Report ID: 848
  • Published Date: May 26, 2025
  • Report Format: PDF, PPT

Companies Dominating the Gel Documentation Systems Landscape

    • The global gel documentation systems market is currently experiencing rapid expansion in product pipelines and integration of advanced technologies. For instance, Thermo Fisher and Bio-Rad solidified their revenue shares of 22.3% and 18.4% in this sector by cultivating a new portfolio of AI-integrated and CRISPR-compatible GDS units. Simultaneously, key players in emerging economies, such as India and China, are focusing more on developing cost-effective systems to offer more affordable services and facilities for patients. Following this pathway, Syngene and Tanon concentrated their resources on enhancing cost optimization and localization of production, which further helped them secure 5.1% and 1.6% revenue shares.

      Top 20 of this cohort of innovators include:

      Company Name

      Country

      Market Share

      Industry Focus

      Thermo Fisher Scientific

      U.S.

      22.3%

      AI-integrated digital GDS, cloud analytics (iBright series)

      Bio-Rad Laboratories

      U.S.

      18.4%

      CRISPR-compatible systems, fluorescence-based GDS (ChemiDoc)

      GE Healthcare

      U.S.

      12.5%

      Sustainable (LED) GDS, high-throughput systems

      Azure Biosystems

      U.S.

      8.1%

      Portable GDS for emerging markets

      LI-COR Biosciences

      U.S.

      7.4%

      OEM partnerships, infrared imaging systems

      Syngene International

      India

      xx%

      Cost-effective GDS for CROs and academia

      Cleaver Scientific

      UK

      xx%

      Compact benchtop systems, UV/fluorescence options

      Vilber Lourmat

      France

      xx%

      Fluorescence GDS for proteomics

      ATTO Corporation

      Japan

      xx%

      High-sensitivity CCD systems for genomics

      Wealtec Corporation

      Taiwan

      xx%

      Budget-friendly GDS for SMEs

      Carestream Health

      U.S.

      xx%

      Medical imaging-integrated GDS

      Corning Incorporated

      U.S.

      xx%

      Consumables (gels, filters) for GDS

      Tanon Science & Technology

      China

      xx%

      Localized GDS production for APAC markets

      Bioraptor

      Australia

      xx%

      Portable GDS for field diagnostics

      Daihan Scientific

      South Korea

      xx%

      Automated GDS for high-volume labs

      Isogen Life Science

      Netherlands

      xx%

      Customizable GDS for niche applications

      Scie-Plas

      UK

      xx%

      UV transilluminators and accessories

      MRC Laboratory

      Malaysia

      xx%

      Affordable GDS for Southeast Asia

      UVItec Limited

      UK

      xx%

      Compact systems for academic labs

      Thomas Scientific

      U.S.

      xx%

      Distribution partnerships with regional manufacturers

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of gel documentation systems is estimated at USD 450.1 million.

Gel Documentation Systems Market size was valued at USD 420.4 million in 2024 and is likely to cross 950.2 million by 2037, expanding at more than 7.1% CAGR during the forecast period i.e., between 2025-2037.

North America industry is set to hold 40.2% largest revenue share by 2037, impelled by highly developed biotechnology research infrastructure, rising research and development by pharmaceutical and biotechnology companies, and availability of government grants in order to support research.

The major players in the market are Bio-Rad laboratories, Inc., Analytik Jena AG, Syngene, TBG diagnostics limited, Thermo Fisher Scientific, Inc., Eikonix, GE Healthcare, ProteinSimple, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos